1. Introduction {#sec1-ijerph-15-02531}
===============

Benzene, a ubiquitous environmental pollutant and a recognized human carcinogen \[[@B1-ijerph-15-02531],[@B2-ijerph-15-02531],[@B3-ijerph-15-02531],[@B4-ijerph-15-02531]\], easily enters the human body through the respiratory tract and skin, which leads to chronic benzene poisoning and hematopoietic dysfunction. The main manifestations of its hematotoxicity are low bone marrow (BM) hyperplasia and peripheral blood cell count \[[@B5-ijerph-15-02531]\]. At present, it is believed that the toxicity of benzene is mainly caused by the metabolites of benzene. Benzene and its metabolites can cause hematopoietic toxicity through many mechanisms, such as oxidative damage, gene mutation, and epigenetic change \[[@B5-ijerph-15-02531],[@B6-ijerph-15-02531]\]. The metabolites of benzene include phenol, hydroquinone, catechol, and 1,4-benzoquinone \[[@B7-ijerph-15-02531]\]. 1,4-benzoquinone can combine directly with biomolecules to produce reactive oxygen species (ROS), cause lipid peroxidation, and eventually result in acute oxidative damage \[[@B8-ijerph-15-02531],[@B9-ijerph-15-02531],[@B10-ijerph-15-02531],[@B11-ijerph-15-02531]\].

Hematopoietic stem cells (HSCs) exist in hematopoietic niches. The hypoxic microenvironment helps to maintain their energetic metabolism mainly based on anaerobic glycolysis, which is necessary to keep their stemness and quiescence \[[@B12-ijerph-15-02531],[@B13-ijerph-15-02531]\]. It is now well established that HIF-1α is highly expressed in long term proliferating HSCs \[[@B14-ijerph-15-02531]\]. Hypoxia inducing factors, especially cell signaling produced by HIF-1α, maintains the quiescence, survival, and metabolic phenotype of HSCs \[[@B15-ijerph-15-02531],[@B16-ijerph-15-02531],[@B17-ijerph-15-02531]\]. HIF-1α not only controls the microenvironment of HSCs through increasing anaerobic glycolysis, but also reduces the production of ROS by inhibiting the activity of nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs) \[[@B18-ijerph-15-02531],[@B19-ijerph-15-02531],[@B20-ijerph-15-02531]\]. The hypoxic environment of HSCs is beneficial in reducing the generation of endogenous ROS \[[@B21-ijerph-15-02531],[@B22-ijerph-15-02531]\].

We previously \[[@B23-ijerph-15-02531]\] found that the intracellular levels of ROS in benzene poisoning male C57BL/6 mice at different concentrations were increased with a significant fall in the expression of HIF-1α, indicating that HIF-1α was involved in damage in the mouse hematopoietic system induced by benzene. Hypoxia inducible factor-1 (HIF-1) is a heterodimeric transcription factor that consists of a constitutively expressed subunit, hypoxia-inducible factor-1β (HIF-1β), and a subunit regulated by the cellular O~2~ concentration, HIF-1α \[[@B23-ijerph-15-02531],[@B24-ijerph-15-02531],[@B25-ijerph-15-02531]\]. Under the condition of hypoxia, the pathway of ubiquitination and proteasomal degradation is blocked, which results in stable HIF-1α protein expression. Thus, HIF-1α combines with the β subunit (HIF-1β) to form HIF-1, then translocates into the nucleus. The transcriptional coactivator p300 (CBP/p300) binds to the hypoxia response element (HRE) sequence on the downstream gene to initiate or enhance the transcription of the effector gene \[[@B26-ijerph-15-02531],[@B27-ijerph-15-02531],[@B28-ijerph-15-02531]\]. Finally, many pathways are regulated, such as cell proliferation, apoptosis, angiogenesis, and erythrocyte maturation \[[@B29-ijerph-15-02531]\]. HRE is the DNA-binding site of HIF-1α. The target genes of HIF-1α, such as Vascular endothelial growth factor (VEGF), Erythropoietin (EPO) \[[@B30-ijerph-15-02531],[@B31-ijerph-15-02531]\], phosphoglycerate kinase 1 (PGK1), Lactate dehydrogenase A (LDHA) \[[@B32-ijerph-15-02531]\], insulin-like growth factor (IGF) \[[@B33-ijerph-15-02531]\], and Bmi1 \[[@B34-ijerph-15-02531],[@B35-ijerph-15-02531]\], have the site sequence on the HRE.

Regulation of HIF-1α is essential in bone marrow hematopoietic toxicity induced by benzene, but the specific mechanism has not been clarified. Chromatin immunoprecipitation sequencing (ChIP-Seq) is a high throughput method for detecting DNA histone modification in the whole genome by combining ChIP with sequencing technology. There are many HIF-1α target genes, and little is known whether these target genes are related to benzene hematotoxicity. In this study, ChIP-Seq was used to analyze the genome-wide binding spectrum of HIF-1α in mouse bone marrow cells. The purpose of this research is to explore specific HIF-1α downstream target genes and pathways by which HIF-1α participates in hematotoxicity caused by benzene.

2. Materials and Methods {#sec2-ijerph-15-02531}
========================

2.1. Reagents {#sec2dot1-ijerph-15-02531}
-------------

1,4-Benzoquinone and 37% formaldehyde solution were purchased from Sigma Co. (Sigma, St. Louis, MO, USA). Corn oil was obtained from COFCO (Beijing, China). The Chip Enzymatic Chromatin IP Kit was purchased from Univ Corp (CST, Danvers, MA, USA). The HIF-1α antibody was supplied by Univ Corp (NOVUS, Littleton, CO, USA).

2.2. Animals, Treatments, and Blood Routine Examination {#sec2dot2-ijerph-15-02531}
-------------------------------------------------------

Male C57BL/6 mice aged 5--6 weeks (weighing 20 g ± 2 g) were purchased from the Animal Core Facility of Nanjing Medical University. Mice (*n* = 24) were randomly divided into three groups and exposed to benzene (vehicle: corn oil) at doses of 0 mg/kg body weight (b.w.) (Control, C), 150 mg/kg b.w. (Low Benzene, LB), and 300 mg/kg b.w. (High Benzene, HB) by subcutaneous injections for 15 consecutive days. The mice were killed by dislocation of cervical vertebrae. After 75% alcohol immersion for 5 min, the hind limbs of the mice were cut with scissors, and the skin and muscles were removed. The bone was cut off at both ends to expose the bone marrow cavity. Bone marrow cells were obtained by washing the bone marrow cavity with 1 mL of sterile phosphate buffered saline (PBS) using a syringe. The whole bone marrow cells were collected and fixed, then the HIF-1α antibody was used to capture the chromatin for later experiments. During the process of exposure, the general changes of mental status, behavioral activities, and food intake of the mice were observed daily. Blood samples were taken from eyeballs (EDTA anticoagulant). Hematological parameters, such as white blood cells (WBC), red blood cells (RBC), and platelets (Plt), were measured by an automatic blood cell counting instrument. This study has been approved by the Research Ethics Committee of the Southeast University (approval number: 20140618).

2.3. Chromatin Immunoprecipitation (ChIP) Assay {#sec2dot3-ijerph-15-02531}
-----------------------------------------------

Approximately 4 × 10^6^ BM cells were required per experiment. Briefly, cells were cross-linked with 0.54 mL 37% formaldehyde that was added to the minimal cell culture medium and mixed thoroughly for 10 min at room temperature, and the crosslinking was then quenched with 2 mL 10× glycine for 5 min. Cross-linked cells were washed twice with ice-cold PBS, and resuspended in 1 mL ice-cold lysis buffer with 5 μL protease inhibitor cocktail (PIC) and 5 μL phenyl-methylsulfonyl fluoride (PMSF). Cells were then resuspended and incubated on ice for 30 min. Subsequently, cell lysate was sonicated to shear chromatin to an average length of 150--900 base pairs (bp) and centrifuged for 10 min at 15,000 rpm in a 4 °C microcentrifuge. To each reaction tube, 10 μg sheared chromatin DNA was added, followed by 1 × ChIP buffer to a total volume of 500 μL, and then it was mixed on ice. Ten microliters of the samples were absorbed from each tube as 2% samples for input control (Input). Ten micrograms of chromatin was immunoprecipitated overnight at 4 °C with 2 μL of HIF-1α antibody (NOVUS), and 2 μL of control IgG antibody (Cell Signaling) or 10 μL of negative control protein H3 antibody (Cell Signaling). Thirty microliter Protein G Magnetic Beads (Millipore) were added and incubated for 2 h at 4 °C. Beads were successively washed with 1 mL of different buffers: Low-salt immune complex wash buffer (300 μL 10× ChIP buffer, 2.7 mL water) and high-salt immune complex wash buffer (100 μL 10× ChIP buffer, 900 μL water). Fifty microliters of the reverse cross-linking buffer was added to the eluted chromatin and the supernatant was then transferred. Finally, all tubes were incubated with 6 μL of 5 mol/L NaCl and 2 μL of proteinase K at 65 °C for 2 h. The DNA was purified by centrifuge column. The DNA from ChIP was quantified via Quant IT fluorescence assay (Life Technologies, Waltham, MA, USA). Illumina sequencing libraries were generated with the NEBNext^®^ Ultra™ DNA Library Prep Kit (New England Biolabs, Ipswich, MA, USA) following the manufacturer's manual. The library quality was determined by using the Agilent 2100 Bioanalyzer (Agilent, Santa Clara, CA, USA), and then subjected to high-throughput 150 bp-end sequencing on a Illumina Hiseq sequencer.

2.4. Data Analysis {#sec2dot4-ijerph-15-02531}
------------------

The genes corresponding to the differentially enriched peak located in the promoter region were selected by reference to the specific binding site HRE (aCGTG/gCGTG) of HIF-1α. Then, based on the location of the corresponding chromosomal sequences of each gene, the Mouse GRCm38/mm10 database of UCSC was used to find out whether there was a gene sequence corresponding to the differential enrichment peak in these gene sequences. If the HRE site of HIF-1α was found in this sequence, it was initially judged to be a positive gene. Afterwards, the positive genes that were initially screened in the previous step were searched in the Pubmed database for the biological function (gene ontology (GO) biological function). And the genes with clear function were again considered as positive genes.

2.5. Real-Time PCR {#sec2dot5-ijerph-15-02531}
------------------

The screened differentially expressed genes were verified by RT-PCR. The reaction system was 20 μL ([Table 1](#ijerph-15-02531-t001){ref-type="table"}). Primers are shown in [Table 2](#ijerph-15-02531-t002){ref-type="table"}. After RNA extraction, reverse transcription of RNA to cDNA was performed with PrimeScript TM RT Master Mix. The program thermocycler of PCR was performed as follows: The program was started with an initial melt step at 95 °C for 30 s, then 95 °C for 5 s, 60 °C for 34 s, and run for 40 cycles. The *β*-actin was taken as the internal reference gene, and the relative expression level of genes was calculated by the 2^−ΔΔ*C*(t)^ method. The concentration of cDNA we used in the study was 500 ng/μL.

2.6. Statistical Analysis {#sec2dot6-ijerph-15-02531}
-------------------------

Differences among multiple groups were analyzed by one-way analysis of variance (ANOVA) using SPSS 16.0 software (SPSS, Chicago, IL, USA). The comparison between the two groups was conducted by the least significant difference (LSD) test. All data was expressed by mean plus and minus standard deviation. The *p* values \< 0.05 were considered statistically significant.

3. Results {#sec3-ijerph-15-02531}
==========

3.1. Benzene Induced Hematopoietic Toxicity and Increased ROS in Mice {#sec3dot1-ijerph-15-02531}
---------------------------------------------------------------------

Our previous study \[[@B23-ijerph-15-02531]\] demonstrated that red blood cells (RBC), white blood cells (WBC), hemoglobin (Hgb), and platelets (Plt) decreased significantly in 150 mg/kg (LB) and 300 mg/kg (HB) groups, along with a fall in the proportion of HSCs (Control, 0.12%; LB, 0.03%; HB, 0.03%; *p* \< 0.05) \[[@B23-ijerph-15-02531]\]. There was a distinct increase in the ROS level at a dose of 150 mg/kg. Therefore, the following chip samples of the benzene exposure group were selected for the LB group. Finally, according to the results of blood routine, two samples with obvious differences from the LB group and two samples from the control group were selected (L1, L2, C1, C2).

3.2. ChIP-Seq Analysis {#sec3dot2-ijerph-15-02531}
----------------------

The DNA fragments were randomly fragmented by sonication treatment, and the sequenced DNA fragments terminal was mapped at different positions on the genome. Assuming each fragment was 50 in the 200\~300 bp region, it was extended and the resulting signal map ("coverage") was visualized as a typical peak shape. The actual DNA sequence combined by HIF-1α should be located at the maximum point (bottom) of the coverage map; that is, an enriched peak ([Figure 1](#ijerph-15-02531-f001){ref-type="fig"}A). After sequencing, image recognition, base calling, and quality filtering, high quality reads (Raw Data) were generated from the Illumina sequencer ([Table 3](#ijerph-15-02531-t003){ref-type="table"}). Then, trimming the joint sequence, the trimmed reads were aligned to the mouse reference genome (UCSC MM10) for peak calling. By comparing the enriched peak with the mouse genome in the UCSC RefSeq database, the enriched peaks were divided into promoter peaks, upstream peaks, intron peaks, exon peaks, and intergenic peaks ([Figure 1](#ijerph-15-02531-f001){ref-type="fig"}B,C). Then the differentially enriched peaks (DEPs) were further identified by diffReps software and annotated with the latest UCSC RefSeq database to connect the peak information with the gene annotation. Taking advantage of the promoter region (transcriptional start site, TSS--2000\~TSS+2000) on the genes corresponding to the enriched peaks, we performed GO functional analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis to annotate, and speculated the biological functions and pathways that these peaks may participate in.

To gain further insight into biological pathways associated with the significantly up or down-regulated genes identified by HIF-1α, analysis using the Database for Annotation, Visualization, and Data quality control (QC) bioinformatics tool was performed ([Table 4](#ijerph-15-02531-t004){ref-type="table"}, [Figure 2](#ijerph-15-02531-f002){ref-type="fig"}).

3.3. Screening of HIF-1α Responsive Genes {#sec3dot3-ijerph-15-02531}
-----------------------------------------

The reduced differential enrichment peak was located in the promoter region, and then the peak was matched to the corresponding gene. A total of 353 up-regulated and 245 down-regulated enrichment peaks in the promoter region were found in the LB group. The top 15 significantly up-regulated or down-regulated genes were chosen and are shown in [Table 5](#ijerph-15-02531-t005){ref-type="table"}. Among the 245 down-regulated genes, 42 genes containing the HIF-1α specific binding site HRE (aCGTG/gCGTG) in the gene sequence of the differentially enriched region were selected using the UCSC database.

Therefore, we preliminarily confirmed that 42 response genes were the target gene of HIF-1α. By searching for the function in the Pubmed database, we found that there were 25 genes involved in the following functions: Promoting cell proliferation, migration, invasion, growth, and metastasis. Thus, these genes were selected for further validation.

3.4. Gene Ontology (GO) Analysis {#sec3dot4-ijerph-15-02531}
--------------------------------

The ontology covers three domains: Biological Process (BP), Cellular Component (CC), and Molecular Function (MF). It is interesting to note that GOBP terms were related to the cellular process, phosphorus metabolic process, phosphate-containing compound metabolic process, cellular response to stress, and MAPK cascade ([Figure 3](#ijerph-15-02531-f003){ref-type="fig"}).

3.5. Kyoto Encyclopedia of Genes and Genomes (KEGG) Analysis {#sec3dot5-ijerph-15-02531}
------------------------------------------------------------

The genes corresponding to the differentially enriched peaks in the promoter region (TSS--2000\~TSS+2000) were used to analyze the pathway, in order to elucidate and speculate the pathways in which these enriched peaks (proteins) may be involved. Similarly, [Figure 4](#ijerph-15-02531-f004){ref-type="fig"} displays the KEGG pathway, which was significantly enriched in the HIF-1α responsive gene corresponding to the reduced enrichment peaks expressed in the LB benzene treatment group compared with the control group, including the Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Fc epsilon RI signaling pathway, Pyrimidine metabolis, T cell receptor signaling pathway, and Transcriptional misregulation in cancer. The actually matched HIF-1α responsive gene count and name are displayed in [Table 6](#ijerph-15-02531-t006){ref-type="table"}.

3.6. Validation of HIF-1α Target Gene {#sec3dot6-ijerph-15-02531}
-------------------------------------

The mRNA level of HIF-1α target genes was detected in BM cells of C57BL/6 mice between the benzene exposure and control groups by RT-PCR. Then the results of RT-PCR and ChIP-Seq were analyzed together to screen out candidate critical genes. The mRNA level of 11 out of 25 genes was down-regulated in BM cells in 150 mg/kg (LB) and 300 mg/kg (HB) benzene-exposed mice compared with the control group ([Table 7](#ijerph-15-02531-t007){ref-type="table"}).

4. Discussion {#sec4-ijerph-15-02531}
=============

With the wide application of benzene in coatings, dyes, spray paint, and other industries, occupational benzene exposure and its health hazards are important public health issues \[[@B36-ijerph-15-02531]\]. Elucidation of the mechanism of benzene toxicity can provide a scientific basis for finding the early damage markers, and is helpful for prevention and treatment strategies for benzene poisoning.

Benzene enters into the human body mainly through respiratory inhalation and skin contact \[[@B4-ijerph-15-02531]\]. Part of it is excreted from the body and part metabolized in the liver and BM. Firstly, phenol and catecholamine are produced from benzene under the action of cytochrome oxidase in the liver \[[@B7-ijerph-15-02531]\]. Secondly, these compounds are catalyzed by myeloperoxidase (MPO) in BM to be the ultimate carcinogen, benzoquinone. BM is an important target organ of benzene toxicity. Therefore, the BM cells of benzene-exposed mice were selected for ChIP-Seq. ROS levels in quiescent stem cells are kept low, thus supporting their ability for long-term repopulation. Survival in this low-oxygen microenvironment requires significant metabolic adaptation \[[@B37-ijerph-15-02531]\]. Hypoxia inducible factors (HIFs) are the most direct regulatory factor in the hypoxic environment \[[@B38-ijerph-15-02531],[@B39-ijerph-15-02531],[@B40-ijerph-15-02531]\], which can regulate oxidative phosphorylation and glycolysis transformation. In the bone marrow microenvironment, the HIF family is involved in glycolytic metabolism, thereby providing sufficient amounts of ATP to maintain HSC activity.

We firstly reported the genome-wide study of HIF-1α target genes in benzene-exposed mice. Compared with the control group, there were 42 differentially enriched genes in the benzene poisoning group. Through analyzing the GO function and signal pathway of differentially expressed genes, we found that these genes were mainly enriched in signal pathways related to cell apoptosis, differentiation, proliferation, oxidative stress, and the hematopoietic system. In addition, our early results showed that exposure to a certain dose of benzene could induce HIF-1α degradation, and decrease the proportion of hematopoietic stem cells and number of peripheral blood cells \[[@B23-ijerph-15-02531]\]. Thus, the abnormal expression of HIF-1α and its downstream genes may be involved in benzene-induced hematotoxicity.

The GO function of differentially enriched genes and the RT-PCR analysis of mouse bone marrow cells showed that 11 genes were down-regulated in the benzene exposure group compared with the control group. Among them, ipo4 \[[@B41-ijerph-15-02531]\] functions as a transporter of HIF-1α. Ribosomal protein S3a1 (Rps3a1) \[[@B42-ijerph-15-02531]\], calpain 5 (Capn5) \[[@B43-ijerph-15-02531]\], skeletal muscle α-actin 1-encoding gene (Acta1), and ganzyme B (Gzmb) \[[@B44-ijerph-15-02531]\] are all related to cell apoptosis and differentiation. The up-regulation of protein tyrosine phosphatase 4A3 (Ptp4a3) \[[@B45-ijerph-15-02531]\] activates Src kinase, which promotes many cell signaling pathways, and cell proliferation, growth, and migration. Research has shown that RNA-binding motif protein 45 (RBM45) transfers from nucleus to cytoplasm under oxidative stress, and this redistribution regulates Kelch-like ECH-associated protein 1 (KEAP1) protein levels, thereby inhibiting NF-E2-related factor 2 (NRF2) activity and reducing cellular antioxidant responses. However, activation of NRF2 may temporarily protect HSCs from the harmful effects of ROS. Once the ROS level recovers, it promotes the long-term decline of HSC self-renewal \[[@B46-ijerph-15-02531]\]. Elevating ROS levels rise and lead to cell death \[[@B47-ijerph-15-02531]\], which is of great importance in cancer therapy strategies. It has been reported that the Rab GTPase activating protein 1-Like (Rabgap1l)-mediated tyrosine kinase signal transduction pathway plays a major role in the pathogenesis of leukemia \[[@B15-ijerph-15-02531]\]. The role and mechanism of specific HIF-1α response genes deserves further study.

Here, the ChIP-Seq technique was used to study the downstream specific genes and signaling pathways regulated by HIF-1α in benzene-induced hematotoxicity, and to explore the role and molecular mechanism of the ROS mediated HIF-1α pathway in hematotoxicity caused by benzene. Our results demonstrate that HIF-1α coregulated with its target genes and pathways in coping with benzene-induced hematopoietic damage. Further research is needed to find the interaction of HIF-1α target genes in the hematopoietic related signaling pathway. Our study provides new clues for screening critical HIF-1α responsive genes and elucidating the mechanism of benzene hematotoxicity.

5. Conclusions {#sec5-ijerph-15-02531}
==============

Benzene exposure may destroy the bone marrow microenvironment and decrease the expression of HIF-1α, indicating that HIF-1α plays an important role in benzene-induced hematopoietic damage. It is well known that there are many HIF-1α target genes, but which of them participate in benzene toxicity remains unclear. In the present study, the HIF-1α target genes related to benzene toxicity were screened by the ChIP-Seq technique, and we further identified differential HIF-1α responsive genes and pathways following benzene exposure. Eleven HIF-1α down-regulated genes were validated as critical genes, which were involved in HSC self-renewal, cell cycle, differentiation, and apoptosis pathways. This study provides new insight into the mechanism of benzene-induced hematopoietic toxicity.
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![The results of chromatin immunoprecipitation sequencing (ChIP-Seq). Two samples from the low benzene (LB) group and two samples from the control group were selected. (**A**) Enriched peak. (**B**) Peak annotation. The enriched peaks were identified and classified as follows: Promoter peaks, upstream peaks, intron peaks, exon peaks, and intergenic peaks. (**C**) Peaks classification. Of the total generated significant peaks in the control sample (*p* \< 0.0001), 8.17% were within the promoter region, 33.9% were within introns, and 40.84% were within the intergenic region. (**D**) Peak length distribution. The length distribution of the enrichment peak is calculated to infer the length of the DNA binding region. (**E**) ChIP-Seq peaks over chromosomes. The distribution of peaks in the genome was statistically enriched, and the chromosomes in the DNA binding region were viewed as a whole.](ijerph-15-02531-g001){#ijerph-15-02531-f001}

###### 

Quality evaluation of control and LB groups by sequencing library. Two samples from the LB group and two samples from the control group were selected (L1, L2, C1, C2). (**A**) C-Input; (**B**) C1-IP; (**C**) C2-IP; (**D**) L-Input; (**E**) L1-IP; (**F**) L2-IP.
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![Gene ontology (GO) biological process classification. The pie chart shows the GO biological process (GOBP) sequencing result of genes corresponding to the reduced enrichment peak in the 150 mg/kg (LB) group compared to the control group, with the top ten counts of the significant enrichment terms.](ijerph-15-02531-g003){#ijerph-15-02531-f003}

![Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway associated with HIF-1α responsive genes. Through bioinformatics analysis, multiple pathways of HIF-1α differentially binding target genes and HIF-1α coregulated genes were obtained in mice bone marrow (BM) cells compared with the control group. The HIF-1α target genes, which correspond to the reduced enrichment peak in the 150 mg/kg (LB) group, were significantly enriched in the KEGG signaling pathway.](ijerph-15-02531-g004){#ijerph-15-02531-f004}
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###### 

RT-PCR mixture.

  Reagent                              Volume
  ------------------------------------ --------
  DNase/RNase-Free Water               6 μL
  SYBR Green PCR Master mix (Toyobo)   10 μL
  Forward /Reverse primer (100 μM)     0.8 μL
  ROX Reference Dye                    0.4 μL
  cDNA                                 2 μL
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###### 

PCR primer sequences of HIF-1α target genes.

  Gene        Forward Primer           Reverse Primer
  ----------- ------------------------ ------------------------
  *β*-actin   CTATGCTCTCCCTCACGCCA     TCACGCACGATTTCCCTCTC
  Ptp4a3      CCTGTAAGGCAGCCCCAACTA    GTGTCTTAGCCAGGGTTTTATG
  Samd4       CAGACGAGGAAGAGTAGAGGG    ACAGACGCATTACTATCACCAA
  Ifitm3      GAGGACCAAGGTGCTGATGTT    TAGCCTATGCCTACTCCGTGAA
  Gzmb        GCCAGTCTTTGCAGTCCTTTA    CTCTGATTACCCATCGTCCCT
  Acta1       CCTTCTGACCCATACCTACCAT   AAGCCTCACTTCCTACCCTCG
  Rbm45       TTTAGGTTCAGCCAAGAGTGC    CGGGAGAAGTTCAAGGTGTAT
  Capn5       TGATTCCTCTTAGCCTCGTCA    GTGGATTTCACAGGTGGTGTT
  Rps3a1      AGCAAGGCTCACTTCAAACAC    TTAGGAACATCGGGAAGACAC
  Ipo4        AGCCACTCCTCCATGTCTTCC    CATCTTTGGGTTGGGCGTACT
  Asb15       GAGCCTCAGCATAATCTCATC    TATACTTCGCCGTCTCCAATA
  Rabgap1l    AGAGGCGGCTTAGTTGTTTGG    GCGGTCTACCTGTTGATTGCC

ijerph-15-02531-t003_Table 3

###### 

Sequencing reads statistics of the ChIP experiment.

  Name      Raw Reads    Mapped to Reference Genome   Mapped Percentage
  --------- ------------ ---------------------------- -------------------
  C-Input   13,294,498   13,049,446                   98.16%
  C1-IP     16,759,284   16,585,336                   98.96%
  C2-IP     15,330,270   14,798,086                   96.53%
  L-Input   14,177,435   13,932,833                   98.27%
  L1-IP     17,959,618   17,666,744                   98.37%
  L2-IP     16,528,262   15,512,603                   93.86%
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###### 

Quality control (QC) of the ChIP experiment.

  Sample Name   Size (bp)   Concentration (ng/μL)   Concentration (nmol/L)   Volume (μL)   Total Amount (ng)
  ------------- ----------- ----------------------- ------------------------ ------------- -------------------
  C-Input       304         7.98                    39.8                     20            159.6
  C1-IP         336         9.71                    43.7                     20            194.2
  C2-IP         301         10.02                   50.5                     20            200.4
  L-Input       296         7.44                    38.1                     20            148.8
  L1-IP         298         10.74                   54.6                     20            214.8
  L2-IP         298         10.83                   55.1                     20            216.6
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###### 

Significantly changed genes corresponding to the differentially enriched peak.

  Down-Regulated Gene Name   Fold Change   FDR     Up-Regulated Gene Name   Fold Change   FDR
  -------------------------- ------------- ------- ------------------------ ------------- -------
  Olfr1120                   −138.5        0.000   Fpgt                     128.8         0.005
  Hilpda                     −116.3        0.003   Lrriq3                   128.8         0.005
  Ebag9                      −116.3        0.003   Pitpnm2                  113.6         0.007
  Ptp4a3                     −105.4        0.002   Rspry1                   111           0.006
  Rgs1                       −105.4        0.002   Fam192a                  111           0.006
  Tmc1                       −99.9         0.005   Otud1                    106           0.007
  Snx33                      −94.4         0.007   Rab5c                    104.3         0.010
  Spred3                     −94.3         0.007   Edn3                     102.3         0.004
  Snhg17                     −94.3         0.007   Ccdc88a                  97.3          0.007
  Olfr1113                   −94.3         0.007   Sod2                     96.7          0.012
  Commd9                     −89           0.005   Sept9                    96.7          0.012
  Rhno1                      −89           0.005   C330013E15Rik            96.1          0.012
  Foxm1                      −89           0.005   Dynll1                   95.5          0.012
  Pgm5                       −88.9         0.005   Gm13830                  95.5          0.012
  Mug1                       −88.8         0.009   Asnsd1                   94.1          0.007
  Samd4                      −88.8         0.009   4930486L24Rik            90.4          0.012

Note. FDR: The corrected p-value between control (0 mg/kg, C) and benzene exposure (150 mg/kg, LB) groups.
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###### 

Pathway Results.

  Pathway                                     Total   Hits   Target Gene Name
  ------------------------------------------- ------- ------ --------------------------------------
  Jak-STAT signaling pathway                  155     5      CSF2RA, GRB2, PIK3CA, SPRED2, SPRED3
  Natural killer cell mediated cytotoxicity   119     4      GRB2, GZMB, LCP2, PIK3CA
  Fc epsilon RI signaling pathway             70      3      GRB2, LCP2, PIK3CA
  Pyrimidine metabolism                       104     3      CTPS, NT5C3B, TXNRD1
  T cell receptor signaling pathway           105     3      GRB2, LCP2, PIK3CA
  Transcriptional misregulation in cancer     178     4      BCL2A1C, GZMB, JMJD1C, LYL1

Note. Total represents the total count of the genes in the listed pathway. Hits is the actually matched enriched gene number in the pathway.
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###### 

Validation of differentially deregulated genes by RT-PCR.

  Gene       2^−ΔΔ*C*(t)^     
  ---------- ---------------- ----------------
  Ptp4a3     0.11985 \*\*\*   0.07554 \*\*\*
  Samd4      0.10351 \*\*\*   0.04879 \*\*\*
  Ifitm3     0.39707 \*       0.53172
  Gzmb       0.41548          0.35731 \*
  Acta1      0.06175 \*\*     0.11185 \*
  Rbm45      0.70175          0.49878 \*\*
  Capn5      0.08935 \*\*\*   0.06172 \*\*\*
  Rps3a1     0.48881 \*\*\*   0.57754 \*\*
  Ipo4       0.39123 \*\*     0.31920 \*\*
  Asb15      0.09352 \*\*     0.25600
  Rabgap1l   0.23461 \*\*\*   0.41362 \*\*

Note. Transcriptional level of HIF-1α target genes in mouse bone marrow cells. Eleven genes were validated in 150 mg/kg (LB) and 300 mg/kg (high benzene, HB) doses. \* Significant difference compared to the control group, *p* \< 0.05. \*\* Significant difference compared to the control group, *p* \< 0.01. \*\*\* Significant difference compared to the control group, *p* \< 0.001.
